Analysts at Morgan Stanley believe that shares in Crowdstrike (CRWD) stock have hit their peak, revising their forecast to equal weight. Morgan Stanley analyst Keith Weiss on Monday lowered his rating on CRWD stock to equal weight from overweight, citing valuation. The stock is currently trending downward, falling 5% in the past week after hitting resistance at $513.

“CrowdStrike remains a long-term market leader in cybersecurity, well positioned for the increasing platform consolidation we expect in the industry, with direct exposure to AI tailwinds,” said Weiss in a report. “However, with the stock up 50% from April lows and the multiple now reflecting a significant rebound in growth, the near-term opportunity appears fully priced in the shares.” Last week, Piper Sandler analyst Rob Owen also cut his rating on CRWD stock to neutral from overweight. The analyst cites peaking potential as well.

CrowdStrike (CRWD) stock has fallen nearly 1% since last month’s earnings report. Estimates have been broadly trending upward for the stock. In addition, the magnitude of these revisions looks promising once its next earnings report is shared this month. Cloudflare has climbed around 78% so far this year, with the cybersecurity sector seeing its stocks climb in 2025. Analysts see CrowdStrike’s fiscal 2026 profit decreasing 10%, before bouncing 33% in fiscal 2027. Sales are expected to increase by an average 22% over the next four quarters.

Also Read: Microsoft (MSFT): Why Analysts Raised Their July Stock Forecast

Despite the lower revision, the analysts have slightly raised their forecast for Crowdstrike (CRWD) from $490 to $495. CrowdStrike’s shares are quite volatile and have had 17 moves greater than 5% over the last year. In that context, today’s move indicates that there is solid momentum behind CRWD stock. According to CNN analysts, the stock could establish an even further all-time high over the next 12 months. Indeed, the high forecast for CRWD is $575.00, an ROI of 11.85% from current prices. Alternatively, the firm’s median forecast for the stock is a slight dip from its current price of 514.10, back to $500, over the next 12 months.